These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. Ahuja SK, Murphy PM. J Biol Chem; 1996 Aug 23; 271(34):20545-50. PubMed ID: 8702798 [Abstract] [Full Text] [Related]
3. [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. Walz A, Meloni F, Clark-Lewis I, von Tscharner V, Baggiolini M. J Leukoc Biol; 1991 Sep 23; 50(3):279-86. PubMed ID: 1856598 [Abstract] [Full Text] [Related]
4. Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms. Wuyts A, Govaerts C, Struyf S, Lenaerts JP, Put W, Conings R, Proost P, Van Damme J. Eur J Biochem; 1999 Mar 23; 260(2):421-9. PubMed ID: 10095777 [Abstract] [Full Text] [Related]
5. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH. Blood; 1995 Jan 15; 85(2):522-31. PubMed ID: 7812007 [Abstract] [Full Text] [Related]
6. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. Moser B, Schumacher C, von Tscharner V, Clark-Lewis I, Baggiolini M. J Biol Chem; 1991 Jun 05; 266(16):10666-71. PubMed ID: 2037605 [Abstract] [Full Text] [Related]
7. The primary role in biologic activity of the neutrophil chemokines IL-8 and GRO-alpha in cultured nasal epithelial cells. Rudack C, Maune S, Eble J, Schroeder JM. J Interferon Cytokine Res; 2003 Feb 05; 23(2):113-23. PubMed ID: 12744776 [Abstract] [Full Text] [Related]
8. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Strieter RM, Kunkel SL, Burdick MD, Lincoln PM, Walz A. Immunol Invest; 1992 Oct 05; 21(6):589-96. PubMed ID: 1428026 [Abstract] [Full Text] [Related]
9. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10542-6. PubMed ID: 1438244 [Abstract] [Full Text] [Related]
10. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Walz A, Strieter RM. J Clin Invest; 1994 Sep 01; 94(3):1012-8. PubMed ID: 8083342 [Abstract] [Full Text] [Related]
11. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Power CA, Furness RB, Brawand C, Wells TN. Gene; 1994 Dec 30; 151(1-2):333-4. PubMed ID: 7828901 [Abstract] [Full Text] [Related]
12. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Wolf M, Delgado MB, Jones SA, Dewald B, Clark-Lewis I, Baggiolini M. Eur J Immunol; 1998 Jan 30; 28(1):164-70. PubMed ID: 9485196 [Abstract] [Full Text] [Related]
13. Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages. Goodman RB, Strieter RM, Frevert CW, Cummings CJ, Tekamp-Olson P, Kunkel SL, Walz A, Martin TR. Am J Physiol; 1998 Jul 30; 275(1):L87-95. PubMed ID: 9688939 [Abstract] [Full Text] [Related]
14. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78. Bozic CR, Gerard NP, Gerard C. Am J Respir Cell Mol Biol; 1996 Mar 30; 14(3):302-8. PubMed ID: 8845182 [Abstract] [Full Text] [Related]
15. Epithelial-derived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection. Schmouder RL, Streiter RM, Walz A, Kunkel SL. Transplantation; 1995 Jan 15; 59(1):118-24. PubMed ID: 7839412 [Abstract] [Full Text] [Related]
16. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Cerretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP. Mol Immunol; 1993 Mar 15; 30(4):359-67. PubMed ID: 8384312 [Abstract] [Full Text] [Related]
17. Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis. Olszyna DP, Opal SM, Prins JM, Horn DL, Speelman P, van Deventer SJ, van der Poll T. J Infect Dis; 2000 Dec 15; 182(6):1731-7. PubMed ID: 11069246 [Abstract] [Full Text] [Related]
18. Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene. Chang MS, McNinch J, Basu R, Simonet S. J Biol Chem; 1994 Oct 14; 269(41):25277-82. PubMed ID: 7929219 [Abstract] [Full Text] [Related]
19. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, Baggiolini M. J Biol Chem; 1993 Jul 25; 268(21):15419-24. PubMed ID: 8340371 [Abstract] [Full Text] [Related]
20. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG. Cytokine; 2011 Dec 25; 56(3):616-20. PubMed ID: 21940178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]